How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most prevalent cause of liver disease worldwide and afflicts adults and children as currently associated with obesity and insulin resistance. Even though lately some advances have been made to elucidate the mechanism and causes of the disease much remains unknown about NAFLD. The aim of this paper is to discuss the present knowledge regarding the pathogenesis of the disease aiming at the initial steps of NAFLD development, when inflammation impinges on fat liver deposition. At this stage, the Kupffer cells attain a prominent role. This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several compounds bind to TLRs expressed in Kupffer cells and also in hepatic stellate cells, namely methylamine, volatile organic compounds and pathogen-associated molecular patterns, which include LPS, lipoteichoic acid, peptidoglycan, flagellin and unmethylated CpG DNA, and activate inflammatory signaling pathways like the NF-kB [298].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [298]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“Markedly, wild-type mice on chow diet when infused continuously with low-dose LPS developed hepatic steatosis, insulin resistance, and weight gain [54].”
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143 · cited 1×
“TNFα or TNFα receptor knockout obese mice have improved insulin sensitivity compared to wild-type controls [60].”
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 1×
“In Europe and in the United States, it is estimated that 3 out of 10 adults developed NAFLD [1, 2].”
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 2×
“The overflow of free fatty acids (FFAs) coming from lipolysis of adipose tissue is the main contributor to hepatic steatosis [15, 16].”
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160 · cited 2×
“Dietary factors, such as fructose, may contribute to altered intestinal motility, bacterial overgrowth, and increased intestinal permeability which is also associated with NAFLD [67].”
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · cited 2×
“The initial view that considered steatosis as a primary hit and gutderived endotoxin as the second hit determining progression of the disease is now followed by a more complex model where many hits may act in parallel [40].”
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 1×
“When compared to carbohydrates (4,5 kcal/g) or proteins (4 kcal/g), TG provides higher caloric intake (9 kcal/g) [9].”
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765 · cited 1×
“A recent study suggested that fructose consumption may specifically promote lipid deposition in visceral adipose tissue, particularly in men, whereas glucose consumption appears to favor subcutaneous adiposity [36].”
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 2×
“enhanced monocyte recruitment, and increased hepatocyte apoptosis [82].”
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C., & Behling, C. (2006) · Pediatrics · doi:10.1542/peds.2006-1212 · Cited by 1,481 · cited 1×
“In Europe and in the United States, it is estimated that 3 out of 10 adults developed NAFLD [1, 2].”
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333 · cited 2×
“Exacerbated accumulation of fat in the adipose tissue culminates in adipocyte hypertrophy with limitations to lipid storage and recruitment and activation of inflammatory mediators [10, 14].”
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204 · cited 1×
“Moreover, this carbohydrate was reported to stimulate hepatic DNL through increasing the expression of two transcription factors, sterol regulatory elementbinding protein-1c (SREBP-1c) and carbohydrate-responsive element-binding protein (ChREBP), that regulate the activity of lipogenic enzymes [34].”
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136 · cited 1×
“The overflow of free fatty acids (FFAs) coming from lipolysis of adipose tissue is the main contributor to hepatic steatosis [15, 16].”
Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001 · cited 1×
“Macrophage depletion during hepatocyte regeneration was shown to remove the stimuli for hepatocyte differentiation andHPCdifferentiated preferentially into cholangiocyte, forming biliary structures [83].”
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Kawano, Y., & Cohen, D. E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0758-5 · Cited by 969 · cited 1×
“Hepatic accumulation results from a disparity between lipids availability (from circulating lipid uptake and/or de novo lipogenesis (DNL)) and lipid disposal (via fatty acid oxidation and/or production VLDL) in the liver [10, 13, 14].”
Lipotoxicity: when tissues overeat
Schaffer, J. E. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200306000-00008 · Cited by 896 · cited 1×
“Lipid droplets of TG have a protective effect against lipids deposition, preventing the formation of toxic lipids intermediates [18].”
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870 · cited 5×
“Increased levels of plasma IL-6 were associated with augmented inflammation and fibrosis in NAFLD patients [39].”
InfluentialFructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863 · cited 1×
“Consumption of fructose has markedly increased and is estimated to be 2-3 times greater in patients with NAFLD, compared with patients with other liver diseases or healthy control individuals [30, 31].”
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805 · cited 2×
“KCs can be also identified by the general macrophage marker F4/80 or by CD68, which is present in all KCs regardless of their location [65].”
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759 · cited 1×
“This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.”
BackgroundTeff, K. L., Elliott, S. S., Tschöp, M., Kieffer, T. J., Rader, D., Heiman, M., Townsend, R. R., Keim, N. L., D’Alessio, D., & Havel, P. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031855 · Cited by 742 · cited 1×
“neither converted into glycogen nor stimulates postprandial ghrelin or insulin secretion, failing to initiate the central satiety response [33].”
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Inflammasome is a central player in the induction of obesity and insulin resistance
Stienstra, R., van Diepen, J. A., Tack, C. J., Zaki, M. H., van de Veerdonk, F. L., Perera, D., Neale, G. A., Hooiveld, G. J., Hijmans, A., Vroegrijk, I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100255108 · Cited by 727 · cited 1×
“On the other hand, high fat feeding in mice lacking Asc resulted in diminished weigh gain, fat mass, and improved insulin resistance [56, 57], discrepancies that could be attributed to heterogeneities in intestinal microbiota [41].”
Hepatic stellate cells in liver development, regeneration, and cancer
Yin, C., Evason, K. J., Asahina, K., & Stainier, D. Y. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66369 · Cited by 719 · cited 2×
“Additionally, KCs through the secretion of IL-1 and TNFα lead to activation ofNF-κB signaling pathway inHSCpromoting cell survival [78].”
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645 · cited 1×
“Another study showed increased NLPR3 and caspase 1 expression in the liver of NASH patients [58].”
Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., DeVera, M. E., Liang, X., Tör, M., & Billiar, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00579.x · Cited by 641 · cited 5×
“from tissue damage and cell death also signal through PRRs [46].”
InfluentialDixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628 · cited 2×
“In vitro assays demonstrated that these fat-ladenKCsweremore responsive to LPS induced activation when compared to KCs from lean mice [68].”
The role of lipid droplets in metabolic disease in rodents and humans
Greenberg, A. S., Coleman, R. A., Kraemer, F. B., McManaman, J. L., Obin, M. S., Puri, V., Yan, Q.-W., Miyoshi, H., & Mashek, D. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46069 · Cited by 621 · cited 1×
“Hepatic steatosis occurs primarily by the formation of lipid droplets [17] considered to be a noncytotoxic structure of TG storage [10].”
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death
Borradaile, N. M., Han, X., Harp, J. D., Gale, S. E., Ory, D. S., & Schaffer, J. E. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600299-jlr200 · Cited by 564 · cited 1×
“Excessive SFA entering hepatocytes are conducted to the formation of saturated phospholipids that are then integrated into ER membrane bilayers, affecting ER membrane fluidity [24].”
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562 · cited 3×
“Increased plasma concentration of tumor necrosis factor (TNF)-α, portal lipopolysaccharide (LPS), and myeloid differentiation primary response gene (MyD)88 have observed these mice [37].”
Vos, M. B., Kimmons, J. E., Gillespie, C., Welsh, J. A., & Blanck, H. M. (2008) · PubMed · Cited by 536
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522 · cited 1×
“such as TNFα and IFNγ [69] (Figure 1).”
Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520
Solinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J.-L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.011 · Cited by 513 · cited 1×
“Development of hepatocellular carcinoma occurs in about one-third of individuals with cirrhosis [75].”
Inflammasomes in liver diseases
Szabo, G., & Csak, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.035 · Cited by 495 · cited 7×
“Supporting a role for inflammasome in NASH, IL-1 receptor (IL-1R), IL-1β, and IL-1α knockout mice showed attenuation of liver pathology induced by high fat diets [42].”
InfluentialFallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5288 · Cited by 479
Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
Seki, E., & Schnabl, B. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.219691 · Cited by 442 · cited 1×
“potential adverse effects of gut microbiota imbalances [40, 44].”
Tominaga, K., Kurata, J. H., Chen, Y. K., Fujimoto, E., Miyagawa, S., Abe, I., & Kusano, Y. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02208670 · Cited by 406 · cited 1×
“A study that evaluate children in the Japanese population observed that fatty liver may occur in children as young as 6 years of age and is directly related to the degree of obesity and specifically to the abdominal subcutaneous fat thickness [4].”
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
Li, Z. Z., Berk, M., McIntyre, T. M., & Feldstein, A. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807616200 · Cited by 400 · cited 1×
“This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.”
BackgroundFaeh, D., Minehira, K., Schwarz, J.-M., Periasamy, R., Park, S., & Tappy, L. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1907 · Cited by 386
Gastaldelli, A., Kozakova, M., Hφjlund, K., Flyvbjerg, A., Favuzzi, A., Mitrakou, A., & Balkau, B. (2009) · Hepatology · doi:10.1002/hep.22845 · Cited by 377 · cited 1×
“Alternatively, several indexes composed of physical and biochemical parameters such as the fatty liver index (FLI) have been proposed to evaluate NAFLD at the population level [8].”
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343 · cited 1×
“This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.”
BackgroundSoft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors
Assy, N., Nasser, G., Kamayse, I., Nseir, W., Beniashvili, Z., Djibre, A., & Grosovski, M. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/810961 · Cited by 331
Klein, I., Cornejo, J. C., Polakos, N. K., John, B., Wuensch, S. A., Topham, D. J., Pierce, R. H., & Crispe, I. N. (2007) · Blood · doi:10.1182/blood-2007-02-073841 · Cited by 330 · cited 1×
“The KC population can be replenished by bone marrow-derived monocytes [66].”
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis
Roh, Y. S., & Seki, E. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12019 · Cited by 301 · cited 2×
“that recognizes bacteria-derived CpG-containing DNA have been proven critical for several aspects of disease [47, 48].”
Cooperation of Liver Cells in Health and Disease
Kmieć, Z. (2001) · Advances in Anatomy Embryology and Cell Biology · doi:10.1007/978-3-642-56553-3 · Cited by 284
Lewis, G. F. (2002) · Endocrine Reviews · doi:10.1210/er.23.2.201 · Cited by 281
Rizki, G., Arnaboldi, L., Gabrielli, B., Yan, J., Lee, G. S., Ng, R. K., Turner, S. M., Badger, T. M., Pitas, R. E., & Maher, J. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600198-jlr200 · Cited by 258 · cited 1×
“Similar results have been observed in animal models of progressive liver disease, where SCD1 expression was highly suppressed with consequent decrease in esterification of SFA into TG, thus promoting liver injury [20, 22].”
Chalasani, N., Wilson, L., Kleiner, D. E., Cummings, O. W., Brunt, E. M., & Ünalp, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.016 · Cited by 253 · cited 1×
“A lower intake of proteins and zinc was also shown in these patients [28].”
Koehler, E. M., Schouten, J. N. L., Hansen, B. E., van Rooij, F. J. A., Hofman, A., Stricker, B. H., & Janssen, H. L. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.028 · Cited by 251 · cited 2×
“More interestingly, the subjects with advanced age show a decrease incidence of NAFLD suggesting the possibility of positive selection of elderly without NAFLD [6].”
Leroux, A., Ferrere, G., Godie, V., Cailleux, F., Renoud, M.-L., Gaudin, F., Naveau, S., Prévot, S., Makhzami, S., Perlemuter, G., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.028 · Cited by 246 · cited 1×
“These results are in accordance with another study [70] where depletion of KCs protected against the development of high fat or high sucrose-induced steatosis.”
Fructose: It’s “Alcohol Without the Buzz”
Lustig, R. H. (2013) · Advances in Nutrition · doi:10.3945/an.112.002998 · Cited by 240
New Insights into Functional Aspects of Liver Morphology
Malarkey, D. E., Johnson, K., Ryan, L., Boorman, G., & Maronpot, R. R. (2005) · Toxicologic Pathology · doi:10.1080/01926230590881826 · Cited by 236 · cited 1×
“[63].”
Csak, T., Velayudham, A., Hritz, I., Petrasek, J., Levin, I., Lippai, D., Catalano, D., Mandrekar, P., Dolganiuc, A., Kurt-Jones, E., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00163.2009 · Cited by 229 · cited 1×
“Amelioration of steatosis and NASH achieved by TLR4 deficiency in several diet-induced mouse models of NAFLD has placed this molecule at the center of inflammation driven pathology [37, 43, 48, 52, 53].”
The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-like Receptors
Lee, J. Y., & Hwang, D. H. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)12877-9 · Cited by 196 · cited 1×
“This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.”
BackgroundImmune and inflammatory pathways in NASH
Ganz, M., & Szabo, G. (2013) · Hepatology International · doi:10.1007/s12072-013-9468-6 · Cited by 184 · cited 1×
“matory mediators that promote liver steatosis and organ inflammation [10, 45].”
The innate immune response during liver inflammation and metabolic disease
Bieghs, V., & Trautwein, C. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.005 · Cited by 175 · cited 19×
“In quiescent state, HSCs store large amounts of Vitamin A in lipid droplets and can be identified by expression of desmin and glial fibrillary acidic protein (GFAP) [76].”
InfluentialNonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben, N., Shiri‐Sverdlov, R., Koonen, D. P. Y., & Hofker, M. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.004 · Cited by 167 · cited 1×
“…2015 Academic Editor: Maria Carmen Collado Copyright © 2015 Nádia Duarte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodInterleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H., Kubicka, S., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50268 · Cited by 167
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors
Dongiovanni, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12945 · Cited by 145 · cited 18×
“In quiescent state, HSCs store large amounts of Vitamin A in lipid droplets and can be identified by expression of desmin and glial fibrillary acidic protein (GFAP) [76].”
InfluentialMeli, R., Mattace Raso, G., & Calignano, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00177 · Cited by 137 · cited 10×
“This lipid deposition within hepatocytes is described as hepatic steatosis and it has been suggested to occur due to three main factors: (1) TG coming from lipolysis of adipose tissue; (2) TG synthetized fromDNL; and (3) TG from diet; with each one contributing about 59%, 26%, and 15%, respectively, to TG accumulation…”
InfluentialEndoplasmic reticulum: nutrient sensor in physiology and pathology
Mandl, J., Mészáros, T., Bánhegyi, G., Hunyady, L., & Csala, M. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.01.003 · Cited by 123 · cited 1×
“This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.”
BackgroundInterleukins in chronic liver disease: lessons learned from experimental mouse models
Tacke, F., & Hammerich, L. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43737 · Cited by 120 · cited 1×
“carcinogenesis induction by diethylnitrosamine (DEN) treatment [61].”
Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes
Moretti, J., & Blander, J. M. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.11.003 · Cited by 107
Autophagy: A Multifaceted Partner in Liver Fibrosis
Mallat, A., Lodder, J., Teixeira-Clerc, F., Moreau, R., Codogno, P., & Lotersztajn, S. (2014) · BioMed Research International · doi:10.1155/2014/869390 · Cited by 93 · cited 1×
“Of note, impairment inKCs phagocytosis has been observed in high fat and high cholesterol diet-inducedmouse models of NAFLD [84].”
Tang, T., Sui, Y., Lian, M., Li, Z., & Hua, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081949 · Cited by 82 · cited 1×
“Accordingly, in vitro stimulation of mouse KCs with the SFA palmitic acid was shown to upregulate expression of TLR receptors [71].”
Forbes, S., Taylor-Robinson, S. D., Patel, N., Allan, P., Walker, B. R., & Johnston, D. G. (2011) · Diabetologia · doi:10.1007/s00125-010-2009-0 · Cited by 81 · cited 1×
“Review Article How Inflammation Impinges on NAFLD:”
Effect of Anaplerotic Fluxes and Amino Acid Availability on Hepatic Lipoapoptosis
Noguchi, Y., Young, J. D., Aleman, J. O., Hansen, M. E., Kelleher, J. K., & Stephanopoulos, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049478 · Cited by 72 · cited 1×
“Oleate alone increased TG accumulation without cell damage and in combination with palmitate and promoted lipid droplet formation abolishing the palmitate effect [21].”
Wang, D. Q. ‐., Portincasa, P., & Neuschwander‐Tetri, B. A. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130001 · Cited by 44
Sawada, K., Ohtake, T., Hasebe, T., Abe, M., Tanaka, H., Ikuta, K., Suzuki, Y., Fujiya, M., Hasebe, C., & Kohgo, Y. (2013) · Hepatology Research · doi:10.1111/hepr.12199 · Cited by 36 · cited 1×
“mice where JNK1 signaling was disrupted in hematopoietic cells [73].”
Nunes, P. M., Wright, A. J., Veltien, A. A., van Asten, J. J. A., Tack, C. J., Jones, J. G., & Heerschap, A. (2014) · The FASEB Journal · doi:10.1096/fj.13-241208 · Cited by 33
Betzel, B., & Drenth, J. P. H. (2014) · BMC Medicine · doi:10.1186/s12916-014-0152-z · Cited by 3
Research works printed but not linked: 6
- 10.1172/jci200523621 · DOI · Paper page
- 2005, Obesity Research, 13, A31
- 2008, The Medscape Journal of Medicine, 10
- 10.1172/JCI200525102 · DOI · Paper page
- 2001, Advances in Anatomy, Embryology, and Cell Biology, 161, 3
- 10.1172/JCI200524282 · DOI · Paper page
Cited by
Ginwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 588
“Excessive accumulation of fat and the presence of circulating free fatty acids contribute to oxidative damage, immune system activation, and dysregulation of cytokine pathways through recognition by PRRs such as toll-like receptors (TLR)s, in particular, TLR4 [92].”
BackgroundInnate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
“This cell type derives from circulating monocytes and represents around 15% of the liver cells being the largest tissuespecific reservoir of macrophages in the body [45].”
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Chen, H., Tan, H., Wan, J., Zeng, Y., Wang, J., Wang, H., & Lu, X. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108391 · Cited by 311
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
Yan, T., Yan, N., Wang, P., Xia, Y., Hao, H., Wang, G., & Gonzalez, F. J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.017 · Cited by 224
Pathogenesis of nonalcoholic steatohepatitis
Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 221
“In addition, Kupffer cells can also be activated by diacylglycerol, ceramide, cholesterol, oxidized lipoproteins, and engulfment of apoptotic hepatocytes [174, 189].”
Metadata
- Authors
- Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P.
- Affiliations
- Instituto Gulbenkian de Ciência (PT)
- Instituto Gulbenkian de Ciência (IGC), Rua da Quinta Grande 6, 2780-156 Oeiras, Portugal
- Associacao Protectora dos Diabeticos de Portugal (PT)
- Corresponding author
- Macedo, M. Paula
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-11
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4450298
- OpenAlex
- W1483567609
- Cited by
- 120
- References
- 86
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 16 · 2022: 17 · 2021: 14 · 2020: 13 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 8 · 2015: 2
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Fundação para a Ciência e a Tecnologia (PTDC/DTP-EPI/0207/2012, PTDC/BIM-MET/0486/2012)
- Portuguese Diabetes Society (PTDC/DTP-EPI/0207/2012, PTDC/BIM-MET/0486/2012)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, Kupffer cells, liver inflammation, pathogenesis, hepatic steatosis, obesity, insulin resistance, macrophages
- MeSH terms
- Humans, Inflammation, Insulin Resistance, Kupffer Cells, Liver, Obesity, Risk Factors, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.